N. Dachicourt et al., DECREASED GLUCOSE-INDUCED CAMP AND INSULIN RELEASE IN ISLETS OF DIABETIC RATS - REVERSAL BY IBMX, GLUCAGON, GIP, American journal of physiology: endocrinology and metabolism, 34(4), 1996, pp. 725-732
The first aim of the study was to investigate the possibility that a d
efect on the islet adenosine 3',5'-cyclic monophosphate (cAMP) product
ion could be involved in the failure of the glucose-induced insulin se
cretion in the neonatal streptozotocin diabetic rats. Exposure to gluc
ose concentration that induced a rise of the cAMP content in the contr
ol islets did not elicit any significant increase in cAMP in diabetic
islets. Forskolin, isobutyl methylxanthine (IBMX), glucagon, or pertus
sis toxin amplified the cAMP accumulation and the insulin release to t
he same extent in both types of islets. Somatostatin, prostaglandin E(
2), UK-14304, or galanin inhibited cAMP accumulation and insulin relea
se to the same extent in both types of islets. Our second purpose was
to investigate whether the use of activators of adenylate cyclase coul
d restore the beta-cell competence to glucose in diabetic rats. The ad
dition of IBMX, glucagon, or gastric inhibitory polypeptide (GIP) to p
erifused islets of diabetic rats amplified their insulin response to g
lucose, and a clear biphasic pattern of the release was regained. In c
onclusion, although there is no major alteration of the functionality
of the adenylate cyclase in the beta-cells of the diabetic rats, we ha
ve identified a defective glucose-induced cAMP generation that could b
e explained by a block in the step(s) linking glucose metabolism and a
ctivation of adenylate cyclase.